Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A three-dimensional model of the human blood-brain barrier to analyse the transport of nanoparticles and astrocyte/endothelial interactions.

Sreekanthreddy P, Gromnicova R, Davies H, Phillips J, Romero IA, Male D.

Version 2. F1000Res. 2015 Nov 17 [revised 2016 Jan 1];4:1279. doi: 10.12688/f1000research.7142.2. eCollection 2015.

2.

Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro.

Gromnicova R, Davies HA, Sreekanthreddy P, Romero IA, Lund T, Roitt IM, Phillips JB, Male DK.

PLoS One. 2013 Dec 5;8(12):e81043. doi: 10.1371/journal.pone.0081043. eCollection 2013.

3.

Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/Visfatin/NMPRTase for glioma therapy.

Chandra N, Bhagavat R, Sharma E, Sreekanthreddy P, Somasundaram K.

J Clin Bioinforma. 2011 Jan 20;1(1):5. doi: 10.1186/2043-9113-1-5.

4.

Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.

Sreekanthreddy P, Srinivasan H, Kumar DM, Nijaguna MB, Sridevi S, Vrinda M, Arivazhagan A, Balasubramaniam A, Hegde AS, Chandramouli BA, Santosh V, Rao MR, Kondaiah P, Somasundaram K.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1409-22. doi: 10.1158/1055-9965.EPI-09-1077.

5.

Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.

Santosh V, Arivazhagan A, Sreekanthreddy P, Srinivasan H, Thota B, Srividya MR, Vrinda M, Sridevi S, Shailaja BC, Samuel C, Prasanna KV, Thennarasu K, Balasubramaniam A, Chandramouli BA, Hegde AS, Somasundaram K, Kondaiah P, Rao MR.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1399-408. doi: 10.1158/1055-9965.EPI-09-1213. Epub 2010 May 25.

Supplemental Content

Loading ...
Support Center